NCT00079469View on ClinicalTrials.gov

Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke

NACompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2004

Study Completion Date

August 31, 2004

Conditions
Cancer SurvivorUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BEHAVIORAL

smoking cessation intervention

DRUG

bupropion hydrochloride

Trial Locations (1)

20852

Tobacco Control Research Branch, Rockville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00079469 - Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke | Biotech Hunter | Biotech Hunter